Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Prices Offering of Euro-denominated Senior Notes

NEW YORK(GenomeWeb) – Thermo Fisher Scientific on Monday after the close of the market priced its offering of €640 million ($797 million) of 2 percent senior notes due 2025 at an issue price of 99.68 percent of the principal amount.  

The issuance of the notes is expected to close on or about Nov. 24. The company plans to use net proceeds mainly to repay about $70 million of short-term indebtedness and to repay about $600 million of long-term indebtedness, which consists of outstanding amounts under the company's $5 billion term loan.  

Thermo Fisher filed a prospectus for the euro-denominated offering of the senior notes last week. On Friday, the company issued $800 million in aggregate principal amount of 3.3 percent senior notes due in 2022. 

The joint book-running managers on the offering are HSBC Bank, Deutsche Bank Securities, and RBS Securities.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.